A detailed history of Cape Investment Advisory, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 2,858 shares of TEVA stock, worth $65,076. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,858
Previous 2,858 -0.0%
Holding current value
$65,076
Previous $46.4 Million 10.89%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 21, 2024

BUY
$10.67 - $14.43 $1,536 - $2,077
144 Added 5.31%
2,858 $40.3 Million
Q2 2023

Oct 12, 2023

BUY
$7.2 - $9.47 $734 - $965
102 Added 3.91%
2,714 $20.4 Million
Q1 2023

Oct 12, 2023

BUY
$8.36 - $11.37 $21,836 - $29,698
2,612 New
2,612 $23.1 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Cape Investment Advisory, Inc. Portfolio

Follow Cape Investment Advisory, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cape Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cape Investment Advisory, Inc. with notifications on news.